Incyte (INCY) Net Cash Flow (QoQ) (2010 - 2026)
Incyte (INCY) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.14% |
| Dec 31, 2025 | 28.93% |
| Sep 30, 2025 | 3,313.77% |
| Jun 30, 2025 | -94.25% |
| Mar 31, 2025 | -33.06% |
| Dec 31, 2024 | 20.00% |
| Sep 30, 2024 | 113.43% |
| Jun 30, 2024 | -1,869.82% |
| Mar 31, 2024 | 2,174.49% |
| Dec 31, 2023 | -106.88% |
| Sep 30, 2023 | -70.06% |
| Jun 30, 2023 | 339.69% |
| Mar 31, 2023 | -150.01% |
| Dec 31, 2022 | 2.60% |
| Sep 30, 2022 | 42.85% |
| Jun 30, 2022 | -10.80% |
| Mar 31, 2022 | 241.44% |
| Dec 31, 2021 | -71.28% |
| Sep 30, 2021 | 59.24% |
| Jun 30, 2021 | -19.91% |